A patient with worsening heart failure exhibits increased respiratory distress, jugular venous distention, and peripheral edema. Which nursing intervention is most appropriate to address the patient's current clinical status?

C) Administer prescribed diuretics and monitor urine output closely

A) Increase the patient's oral fluid intake to prevent dehydration

B) Elevate the patient's legs to reduce peripheral edema

C) Administer prescribed diuretics and monitor urine output closely

D) Encourage the patient to ambulate to improve circulation

A patient with a history of heart failure presents with increased respiratory distress, jugular venous distention, crackles in the lung bases, and an S3 heart sound. His oxygen saturation is 88% on room air. Based on these findings, what is the most appropriate initial nursing intervention?

B) Position the patient in a high Fowler's position.

A) Encourage the patient to increase oral fluid intake.

B) Position the patient in a high Fowler's position.

C) Administer a bronchodilator as prescribed.

D) Prepare the patient for immediate intubation.

A patient with worsening heart failure has been transitioned to intravenous furosemide and develops atrial fibrillation with rapid ventricular response. Despite treatment with diltiazem, the patient's renal function continues to decline. Which of the following nursing actions is the highest priority to address the patient's current condition?

B) Monitor the patient's electrolyte levels closely and report any significant changes

A) Increase the rate of intravenous fluids to improve renal perfusion

B) Monitor the patient's electrolyte levels closely and report any significant changes

C) Prepare for possible administration of inotropic agents to support cardiac output

D) Educate the patient and family about the importance of anticoagulation therapy in atrial fibrillation

A patient with worsening heart failure is being managed with intravenous furosemide and has developed atrial fibrillation with rapid ventricular response. Despite starting diltiazem, the patient's renal function is declining with a serum creatinine level of 2.5 mg/dL. What is the most appropriate initial nursing action to address the patient's current condition?

C) Collaborate with the healthcare provider to adjust medications considering renal function.

A) Increase the dose of furosemide to enhance fluid removal.

B) Initiate a fluid restriction to prevent further fluid overload.

C) Collaborate with the healthcare provider to adjust medications considering renal function.

D) Prepare the patient for immediate dialysis to address renal insufficiency.

A patient with atrial fibrillation and heart failure presents with a heart rate of 130 bpm, mild hypotension, hypokalemia, and elevated BNP levels. Which nursing intervention should be prioritized to address the current clinical findings?

B) Administer potassium supplementation to correct the hypokalemia.

A) Increase the rate-controlling medication dosage to lower the heart rate.

B) Administer potassium supplementation to correct the hypokalemia.

C) Initiate inotropic support to improve cardiac output and renal perfusion.

D) Consult nephrology for potential renal replacement therapy.

A patient with a history of heart failure is experiencing atrial fibrillation with rapid ventricular response, mild hypotension, and hypokalemia after intensified diuretic therapy. Which nursing intervention should be prioritized to address these clinical findings?

B) Start potassium supplementation and monitor serum potassium levels closely.

A) Administer additional doses of furosemide to manage pulmonary congestion.

B) Start potassium supplementation and monitor serum potassium levels closely.

C) Increase the rate-controlling medication to manage the atrial fibrillation.

D) Initiate fluid restriction to manage mild hypotension.

A patient with worsening respiratory distress and signs of right-sided heart failure is receiving oxygen therapy via a non-rebreather mask. The healthcare team is considering escalating care to non-invasive ventilation. Which clinical finding would most strongly support the decision to initiate non-invasive ventilation?

C) Confusion and disorientation during nursing assessment

A) Oxygen saturation of 92% on room air

B) Presence of pitting edema in the lower extremities

C) Confusion and disorientation during nursing assessment

D) Respiratory rate of 20 breaths per minute

A patient with worsening pulmonary edema, respiratory distress, and signs of right-sided heart failure is being considered for a change in treatment strategy. Given the patient's current respiratory and cardiovascular status, which of the following interventions should the nurse prioritize to effectively address the patient's acute needs?

C) Initiate non-invasive ventilation to support respiratory function and improve oxygenation.

A) Administer diuretics to manage fluid overload and reduce pulmonary edema.

B) Increase the rate of intravenous fluids to improve cardiac output.

C) Initiate non-invasive ventilation to support respiratory function and improve oxygenation.

D) Encourage the patient to ambulate to promote circulation and reduce edema.

A patient with respiratory acidosis and acute kidney injury is being transitioned to non-invasive positive pressure ventilation (NIPPV). Which nursing intervention is most critical to prioritize in this scenario?

C) Frequently assess the effectiveness of NIPPV on the patient's respiratory status.

A) Monitor the patient's fluid balance and adjust diuretics accordingly.

B) Evaluate the patient's neurological status every four hours.

C) Frequently assess the effectiveness of NIPPV on the patient's respiratory status.

D) Administer sodium polystyrene sulfonate for hyperkalemia.

A patient with acute heart failure and respiratory acidosis is being managed with non-invasive positive pressure ventilation (NIPPV) and milrinone infusion. Given the patient's continuing altered mental status and the current laboratory findings, what immediate nursing action should be prioritized?

C) Prepare for intubation and mechanical ventilation due to inadequate respiratory support.

A) Increase the rate of the milrinone infusion to improve cardiac output.

B) Administer a hypertonic saline solution to correct hyponatremia promptly.

C) Prepare for intubation and mechanical ventilation due to inadequate respiratory support.

D) Increase the dose of diuretics to manage fluid overload more aggressively.

right and left heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism (Right Heart Failure): Increased afterload from pulmonary hypertension causes the right ventricle to work harder, leading to hypertrophy and eventual dysfunction.

• Primary mechanism (Left Heart Failure): Reduced contractility due to myocardial damage (e.g., ischemia) decreases cardiac output, leading to blood pooling in the left atrium and pulmonary circulation.

• Secondary mechanism (Right Heart Failure): Backward pressure from the right atrium causes systemic venous congestion, resulting in peripheral edema and organ congestion.

• Secondary mechanism (Left Heart Failure): Increased pressure in pulmonary veins leads to pulmonary congestion and edema, impairing gas exchange and causing dyspnea.

• Key complication: Progressive heart failure on either side can lead to biventricular failure, where symptoms and complications of both types co-exist, exacerbating clinical deterioration.

Patient Profile

Demographics:

67 years old, male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Coronary Artery Disease

• Current medications: Lisinopril, Metformin, Aspirin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and swelling in legs

• Key symptoms: Fatigue, orthopnea, paroxysmal nocturnal dyspnea, weight gain, persistent cough with frothy sputum

• Vital signs: Blood pressure 160/95 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 91% on room air

Section 1

Change in Patient Status:

As the nursing team continues to monitor the patient, it becomes apparent that his condition is worsening. Over the next 24 hours, the patient's respiratory distress increases, and he develops a new onset of jugular venous distention (JVD), indicating a rise in central venous pressure. His oxygen saturation drops further to 88% on room air, necessitating supplemental oxygen via nasal cannula to maintain adequate oxygenation. Auscultation reveals coarse crackles at the lung bases and an S3 heart sound, suggesting fluid overload and further compromise in cardiac function. The patient's blood pressure remains elevated at 165/98 mmHg, and his heart rate increases to 110 bpm, indicating a compensatory response to maintain cardiac output.

In addition to respiratory and cardiovascular symptoms, the patient exhibits signs of hepatic congestion, as evidenced by mild right upper quadrant tenderness and hepatomegaly on palpation. Laboratory results show worsening kidney function, with an elevated serum creatinine of 2.1 mg/dL from a baseline of 1.3 mg/dL, and a B-type Natriuretic Peptide (BNP) level of 1200 pg/mL, reinforcing the diagnosis of heart failure exacerbation. The patient's fluid intake and output records reveal a positive fluid balance, contributing to his weight gain and peripheral edema.

These developments suggest the progression towards biventricular heart failure, where the left heart failure's pulmonary congestion is now compounded by systemic venous congestion from right heart failure. This complex interaction results in a deteriorating clinical picture, necessitating a reassessment of the current management plan. The healthcare team must consider adjustments to his diuretic therapy, potential inotropic support, and reevaluation of the underlying causes of his heart failure exacerbation, while preparing for potential escalation of care if the patient's condition continues to decline.

Section 2

As the healthcare team implements changes to manage the patient's worsening heart failure, they focus on intensifying diuretic therapy to address the fluid overload. The patient is transitioned to intravenous furosemide, and cautious monitoring of electrolytes is initiated to prevent imbalances. Despite these efforts, the patient develops a new complication: a sudden onset of atrial fibrillation with rapid ventricular response, with a heart rate now spiking to 140 bpm. This arrhythmia further complicates the clinical picture, as it exacerbates the patient's hemodynamic instability and contributes to decreased cardiac output.

The team performs an urgent electrocardiogram (ECG) to confirm the diagnosis of atrial fibrillation, noting the characteristic irregular rhythm and absence of P waves. To manage this new development, the patient is started on a rate-controlling medication, such as diltiazem, to help stabilize his heart rate. Additionally, anticoagulation therapy is considered due to the increased risk of thromboembolic events associated with atrial fibrillation.

Despite these interventions, the patient's renal function continues to decline, as evidenced by a further rise in serum creatinine to 2.5 mg/dL, indicating worsening renal perfusion and potential acute kidney injury. The healthcare team faces a complex scenario requiring critical clinical reasoning to balance fluid management, control of heart rate, and support of renal function. This situation emphasizes the need for close monitoring and potential discussion of advanced therapies, such as inotropic support or even temporary mechanical circulatory support, if the patient's condition does not improve. The team prepares for a possible transfer to a higher level of care to ensure all necessary resources are available to manage this multifaceted heart failure exacerbation effectively.

Section 3

As the healthcare team continues to manage the patient's complex case, they focus on the initial assessment findings to guide their next steps. Despite the administration of rate-controlling medication, the patient's heart rate remains elevated at 130 bpm, reflecting persistent atrial fibrillation with rapid ventricular response. Blood pressure readings show mild hypotension at 98/60 mmHg, indicating compromised cardiac output. The patient reports increasing fatigue and mild shortness of breath, with auscultation revealing crackles in the lower lung fields, suggestive of ongoing pulmonary congestion.

Laboratory results reveal further electrolyte imbalances, with a potassium level dropping to 3.2 mEq/L and a sodium level at 130 mEq/L, raising concerns about the effects of intensified diuretic therapy. The patient's B-type natriuretic peptide (BNP) level has risen to 1,200 pg/mL, confirming the severity of heart failure exacerbation. The rising creatinine level, now at 2.7 mg/dL, underscores the need for cautious management of renal function, as the risk for acute kidney injury increases.

Given these findings, the team engages in critical clinical reasoning to adjust the treatment plan. They decide to cautiously reduce the dose of furosemide while initiating potassium supplementation to address the hypokalemia. The possibility of starting inotropic support is discussed to improve cardiac output and renal perfusion. The team also considers consulting nephrology for potential renal replacement therapy, should the patient's kidney function continue to deteriorate. These decisions are made in preparation for a potential transfer to the intensive care unit, where advanced therapies and continuous monitoring can be implemented to stabilize the patient's condition.

Section 4

As the healthcare team continues to monitor the patient, they note a change in the patient’s status. Despite the adjustments in the treatment plan, the patient’s condition begins to show signs of further deterioration. The patient's respiratory distress intensifies, with increased shortness of breath and oxygen saturation levels dropping to 88% on room air. Auscultation now reveals more pronounced crackles throughout the lung fields, indicating worsening pulmonary edema. The team acts swiftly to initiate supplemental oxygen therapy via a non-rebreather mask, escalating the patient's oxygen support to improve saturation levels.

Concurrent with these respiratory changes, the patient exhibits increasing signs of peripheral edema, with notable pitting edema in the lower extremities and ascites, suggesting the progression of right-sided heart failure. Additionally, there is a concerning development of tachypnea, with a respiratory rate climbing to 28 breaths per minute. The patient's mental status is also subtly altered, with episodes of confusion and disorientation noted during the nursing assessment, which may reflect hypoxia or evolving metabolic disturbances.

Given these developments, the team is prompted to reconsider their approach. They deliberate on the necessity of escalating care, discussing the use of non-invasive ventilation to better manage the patient's respiratory status. The decision is made to re-evaluate the patient's medication regimen, considering the introduction of milrinone to support cardiac function and address the ongoing hemodynamic instability. The team also prioritizes obtaining repeat laboratory tests, particularly focusing on arterial blood gases, to gain insight into the patient's respiratory and metabolic status. These steps are crucial as the team prepares for the possibility of transfer to the intensive care unit, recognizing the need for closer monitoring and advanced interventions to stabilize the patient's condition.

Section 5

As the healthcare team continues to manage the patient's deteriorating condition, they receive the results of the repeat laboratory tests. The arterial blood gas analysis reveals a significant respiratory acidosis with a pH of 7.28, PaCO2 of 56 mmHg, and PaO2 of 60 mmHg, confirming inadequate ventilation and severe hypoxemia. The metabolic panel indicates worsening renal function, with elevated creatinine at 2.1 mg/dL and BUN at 45 mg/dL, suggesting acute kidney injury likely due to poor perfusion secondary to cardiac dysfunction. Electrolyte imbalances are also noted, with hyponatremia at 128 mmol/L and mild hyperkalemia at 5.6 mmol/L, necessitating careful management to prevent further complications.

In response to these diagnostic findings, the team intensifies therapeutic interventions. The decision is made to transition the patient from a non-rebreather mask to non-invasive positive pressure ventilation (NIPPV) to improve alveolar ventilation and address the respiratory acidosis. Milrinone is initiated as planned, with the aim of enhancing inotropic support and reducing afterload, thereby improving cardiac output and perfusion. Diuretic therapy is adjusted to address the fluid overload contributing to both the pulmonary and peripheral edema, while closely monitoring renal function and electrolyte levels.

Despite these interventions, the patient continues to exhibit altered mental status, with increased confusion and agitation. Neurological assessment reveals a Glasgow Coma Scale score of 13, indicating moderate impairment. Recognizing the potential for further deterioration, the healthcare team prepares for the transfer to the intensive care unit for more intensive monitoring and management. The patient’s dire need for hemodynamic stabilization and respiratory support underscores the urgency of this transfer, as the team anticipates the possibility of mechanical ventilation should the non-invasive measures prove insufficient.